Amneal Pharmaceuticals, Inc. AMRX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $78M+57.3% | $49.57M+173% | $18.13M-49.1% | $35.61M+44.7% | $24.62M+219% | ||
| $8.82M+7.5% | $8.2M-0.2% | $8.22M-0.7% | $8.27M+14.0% | $7.26M+0.7% | ||
| -$26.74M-121% | $130.32M+10.0% | $118.45M+41.3% | $83.82M+1,031% | $7.41M-93.7% | ||
| $8.18M-62.5% | $21.77M+77.0% | $12.3M-46.1% | $22.83M+73.5% | $13.16M-13.2% | ||
| -$21.71M+52.2% | -$45.45M-102% | -$22.46M+15.4% | -$26.55M-49.2% | -$17.8M-10.8% | ||
| $134.67M-94.6% | $2.48B— | $0-100% | $218M— | $0+100% | ||
| -$59.06M-484% | -$10.12M— | —— | -$41.69M-6.4% | -$39.17M+36.0% | ||
| -$108.53M-246% | $74.53M-51.8% | $154.74M+913% | $15.28M+131% | -$50.03M-225% | ||
| -$34.92M-132% | $108.54M+2.3% | $106.15M+74.1% | $60.99M+1,160% | -$5.75M-106% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Amneal Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Amneal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.